1. Home
  2. ATYR vs AMPX Comparison

ATYR vs AMPX Comparison

Compare ATYR & AMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • AMPX
  • Stock Information
  • Founded
  • ATYR 2005
  • AMPX 2008
  • Country
  • ATYR United States
  • AMPX United States
  • Employees
  • ATYR N/A
  • AMPX N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • AMPX Industrial Machinery/Components
  • Sector
  • ATYR Health Care
  • AMPX Miscellaneous
  • Exchange
  • ATYR Nasdaq
  • AMPX Nasdaq
  • Market Cap
  • ATYR 126.3M
  • AMPX 136.6M
  • IPO Year
  • ATYR 2015
  • AMPX N/A
  • Fundamental
  • Price
  • ATYR $2.11
  • AMPX $1.19
  • Analyst Decision
  • ATYR Strong Buy
  • AMPX Strong Buy
  • Analyst Count
  • ATYR 4
  • AMPX 7
  • Target Price
  • ATYR $19.25
  • AMPX $8.17
  • AVG Volume (30 Days)
  • ATYR 541.3K
  • AMPX 1.6M
  • Earning Date
  • ATYR 11-07-2024
  • AMPX 11-07-2024
  • Dividend Yield
  • ATYR N/A
  • AMPX N/A
  • EPS Growth
  • ATYR N/A
  • AMPX N/A
  • EPS
  • ATYR N/A
  • AMPX N/A
  • Revenue
  • ATYR $588,000.00
  • AMPX $12,423,000.00
  • Revenue This Year
  • ATYR N/A
  • AMPX $66.77
  • Revenue Next Year
  • ATYR $2,057.88
  • AMPX $311.17
  • P/E Ratio
  • ATYR N/A
  • AMPX N/A
  • Revenue Growth
  • ATYR N/A
  • AMPX 216.99
  • 52 Week Low
  • ATYR $1.08
  • AMPX $0.61
  • 52 Week High
  • ATYR $2.50
  • AMPX $6.02
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 69.53
  • AMPX 56.97
  • Support Level
  • ATYR $1.83
  • AMPX $0.97
  • Resistance Level
  • ATYR $1.96
  • AMPX $1.38
  • Average True Range (ATR)
  • ATYR 0.09
  • AMPX 0.16
  • MACD
  • ATYR 0.03
  • AMPX 0.04
  • Stochastic Oscillator
  • ATYR 86.27
  • AMPX 65.39

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About AMPX Amprius Technologies Inc.

Amprius Technologies Inc is engaged in the production of silicon anodes for high energy density lithium-ion batteries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. All of its revenues is geographically earned in the United States.

Share on Social Networks: